GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46: 384–390

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Access to Document

@article{df10dd7d526144fc84e2ac06821b3b56,

title = "GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46: 384–390",

author = "Smits, {Mark M.} and {van Raalte}, {Daniel H.}",

year = "2023",

month = may,

day = "1",

doi = "https://doi.org/10.2337/dc23-0134",

language = "English",

volume = "46",

pages = "e120",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "5",

}

TY - JOUR

T1 - GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46

T2 - 384–390

AU - Smits, Mark M.

AU - van Raalte, Daniel H.

PY - 2023/5/1

Y1 - 2023/5/1

UR - http://www.scopus.com/inward/record.url?scp=85159340030&partnerID=8YFLogxK

U2 - https://doi.org/10.2337/dc23-0134

DO - https://doi.org/10.2337/dc23-0134

M3 - Article

C2 - 37185688

SN - 0149-5992

VL - 46

SP - e120

JO - Diabetes Care

JF - Diabetes Care

IS - 5

ER -